SOX2 and cancer: In majority of cancers, SOX2 expression had been predominantly identified in the absence of genetic amplifications and might depend upon yet unknown upstream regulatory mechanisms (Brass et al., 1996; Balsara et al., 1997; Lengerke et al., 2011).